taltz
(ixekizumab)Eli Lilly and Company
Usage: TALTZ is indicated for the treatment of moderate-to-severe plaque psoriasis in patients aged 6 and older, as well as for adults with active psoriatic arthritis, ankylosing spondylitis, and active non-radiographic axial spondyloarthritis with objective signs of inflammation.